Paul Lorigan
PhD, FRCP
Professor of Medical Oncology
👥Biography 个人简介
Paul Lorigan has contributed to the KEYNOTE-054 and related trials establishing anti-PD1 therapy as adjuvant standard of care for resected stage III melanoma. His research has evaluated patient-reported outcomes and quality of life during adjuvant immunotherapy and explored patterns of relapse and salvage treatment options. He is a leading advocate for evidence-based survivorship and follow-up strategies in high-risk melanoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Paul Lorigan 的研究动态
Follow Paul Lorigan's research updates
留下邮箱，当我们发布与 Paul Lorigan（University of Manchester / The Christie）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment